AAPL vs PFE: Which Is the Better Buy?
Side-by-side comparison of Apple Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-13.
Apple Inc. · Technology
$294.80
-9.3% upside to fair value
Grade B-
High Quality
VS
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
QuantHub Verdict
PFE has more upside to fair value
(+28.6%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AAPL |
PFE |
| Current Price |
$294.80 |
$26.33 |
| Fair Value Estimate |
$267.40 |
$33.85 |
| Upside to Fair Value |
-9.3%
|
+28.6%
|
| Market Cap |
$4,329.8B |
$149.8B |
| Forward P/E |
35.4x
|
19.3x
|
| EV / EBITDA |
27.3x
|
12.9x
|
| Price / Sales |
9.6x
|
2.4x
|
| Price / FCF |
33.5x
|
16.5x
|
| Revenue Growth YoY |
+16.6%
|
-1.2%
|
| Gross Margin |
47.9%
|
70.3%
|
| Operating Margin |
32.6%
|
24.7%
|
| Return on Equity |
146.7%
|
8.7%
|
| Dividend Yield |
0.34% |
0% |
| FCF Yield |
2.98%
|
6.06%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Apple Inc. is the world's most valuable consumer technology company, anchored by the iPhone franchise and a roughly $100 billion annual Services business that compounds at a low-to-mid teens rate on an installed base of approximately 2.5 billion active devices. Fiscal Q2 2026 results reported on April 30 showed revenue of $111.2 billion (+16.6% YoY) and EPS of $2.02 (+22.4% YoY), driven by a cont…
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Accumulation Zones
| Metric |
AAPL |
PFE |
| Zone Low |
$200.50 |
$25.39 |
| Zone High |
$227.30 |
$28.77 |
| In Buy Zone? |
No
|
Yes
|